European Prospective Registry on Anomalous Aortic Origin of the Coronary Arteries
EUROAAOCA
EUROAAOCA Registry
1 other identifier
observational
500
2 countries
2
Brief Summary
Anomalous aortic origin of a coronary artery (AAOCA) is a group of rare congenital heart defects with various clinical presentations. The lifetime-risk of an individual living with AAOCA is unknown, and data from multicentre registries are urgently needed to adapt current recommendations and guide optimal patient management. The European Registry for AAOCA (EURO-AAOCA) aims to assess differences with regard to AAOCA management between centres.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2019
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedFirst Submitted
Initial submission to the registry
October 3, 2023
CompletedFirst Posted
Study publicly available on registry
October 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2029
ExpectedOctober 19, 2023
October 1, 2023
6 years
October 3, 2023
October 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Incidence of Symptoms at diagnosis and after surgery
The study will assess the presence of symptoms (angina, chest pain, distress, sudden cardiac death-SCD, syncope, aborted SCD) at diagnosis, and after eventual surgical repair, to assess incidence of symptoms in patients with this anomaly and effectiveness of surgery in removing symptoms.
5 years
Incidence of postoperative adverse events
The study will assess the incidence of operative death and adverse events after surgery (in those who undergo surgery).
5 years
Incidence of adverse events at follow up
The study will assess the incidence of death and adverse events at clinical follow up either in patients who required a surgical repair or in those who did not undergo surgery because of lack of indications.
5 years
Secondary Outcomes (2)
Incidence of any arrhythmias at Follow up
5 years
Rate of return to unrestricted competitive sport
5 years
Study Arms (2)
adult > 30 years
All adult patient \> 30 yrs undergoing diagnosis (incidental or not) of anomalous aortic origin of coronary arteries
Juvenile < 30 yrs
All young patient \<30 yrs undergoing diagnosis (incidental or not) of anomalous aortic origin of coronary arteries
Interventions
unroofing of coronary artery
Eligibility Criteria
all patients undergoing incidental or not diagnosis of AAOCA
You may qualify if:
- All patients with a diagnosis of AAOCA (either referred to surgery or to medical follow-up )
You may not qualify if:
- isolated high-coronary take-off (≥ 5mm above sino-tubular junction), anomalous origin of a circumflex from the right coronary artery, anomalous course with a normal origin, and association to major congenital heart disease (i.e. Tetralogy of Fallot, transposition of the great arteries, anomalous origin of a coronary from the pulmonary artery).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Padovalead
- IRCCS Policlinico S. Donatocollaborator
- Mitera Children's Hospital, Athens Heart Surgery Institute, Greececollaborator
- Ospedale Civile Ca' Foncellocollaborator
- University Hospital, Ghentcollaborator
- Guy's and St Thomas' NHS Foundation Trustcollaborator
- Azienda Ospedaliera Universitaria Integrata Veronacollaborator
- University Medical Center Groningencollaborator
- Hospital Universitario La Pazcollaborator
- Cliniques universitaires Saint-Luc- Université Catholique de Louvaincollaborator
- Insel Gruppe AG, University Hospital Berncollaborator
- Azienda Ospedaliero-Universitaria di Parmacollaborator
Study Sites (2)
Massimo Padalino
Padua, PD, 35128, Italy
Christopher Grani
Bern, Switzerland
Related Publications (6)
Padalino MA, Jegatheeswaran A, Blitzer D, Ricciardi G, Guariento A. Surgery for Anomalous Aortic Origin of Coronary Arteries: Technical Safeguards and Pitfalls. Front Cardiovasc Med. 2021 May 12;8:626108. doi: 10.3389/fcvm.2021.626108. eCollection 2021.
PMID: 34055925RESULTBigler MR, Kadner A, Raber L, Ashraf A, Windecker S, Siepe M, Padalino MA, Grani C. Therapeutic Management of Anomalous Coronary Arteries Originating From the Opposite Sinus of Valsalva: Current Evidence, Proposed Approach, and the Unknowing. J Am Heart Assoc. 2022 Oct 18;11(20):e027098. doi: 10.1161/JAHA.122.027098. Epub 2022 Oct 7.
PMID: 36205254RESULTPonzoni M, Frigo AC, Padalino MA. Surgery for Anomalous Aortic Origin of a Coronary Artery (AAOCA) in Children and Adolescents: A Meta-Analysis. World J Pediatr Congenit Heart Surg. 2022 Jul;13(4):485-494. doi: 10.1177/21501351221095424.
PMID: 35757950RESULTGrani C, Padalino MA. Editorial: Coronary Artery Anomalies: A 2020 Review. Front Cardiovasc Med. 2022 Feb 10;9:776951. doi: 10.3389/fcvm.2022.776951. eCollection 2022. No abstract available.
PMID: 35224033RESULTThiene G, Frescura C, Padalino M, Basso C, Rizzo S. Coronary Arteries: Normal Anatomy With Historical Notes and Embryology of Main Stems. Front Cardiovasc Med. 2021 May 31;8:649855. doi: 10.3389/fcvm.2021.649855. eCollection 2021.
PMID: 34136540RESULTPadalino MA, Franchetti N, Hazekamp M, Sojak V, Carrel T, Frigiola A, Lo Rito M, Horer J, Roussin R, Cleuziou J, Meyns B, Fragata J, Telles H, Polimenakos AC, Francois K, Veshti A, Salminen J, Rocafort AG, Nosal M, Vedovelli L, Guariento A, Vida VL, Sarris GE, Boccuzzo G, Stellin G. Surgery for anomalous aortic origin of coronary arteries: a multicentre study from the European Congenital Heart Surgeons Associationdagger. Eur J Cardiothorac Surg. 2019 Oct 1;56(4):696-703. doi: 10.1093/ejcts/ezz080.
PMID: 30897195RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Massimo Padalino, MD PhD
University of Padova
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 3, 2023
First Posted
October 19, 2023
Study Start
January 1, 2019
Primary Completion
January 1, 2025
Study Completion (Estimated)
January 1, 2029
Last Updated
October 19, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share
The anonymized demographic and clinical data underlying this study can be shared on reasonable request to the principal investigator